When Is Depression Considered Treatment-Resistant?

Treatment-Resistant Depression: When Standard Treatment Isn’t Enough You’ve Tried More Than One Medication. Now What? Trying multiple antidepressants without achieving meaningful, lasting relief can be…

Treatment-Resistant Depression: When Standard Treatment Isn’t Enough

You’ve Tried More Than One Medication. Now What?

Trying multiple antidepressants without achieving meaningful, lasting relief can be discouraging. You may start wondering whether medication simply does not work for you, whether you’ve been given the wrong diagnosis, or whether there are no options left.

Clinically, however, treatment-resistant depression does not simply mean that several medications have failed.

There are important questions to answer first: Were the medications appropriate for your symptoms? Were they taken at an effective dose? Were they continued long enough to evaluate their effect? Were side effects preventing you from taking them consistently? And could another condition be contributing to the symptoms?

Answering these questions can change the picture.

For some people, the next step is not another medication chosen at random. It may be adjusting the current medication, adding another treatment, considering a combination approach, or evaluating whether a different diagnosis or contributing condition has been overlooked.

Treatment resistance is not the same as having no options.

A careful review of your treatment history can help determine what has genuinely been tried, what may still be worth considering, and what the next step should be.

The Clinical Definition

Treatment-resistant depression generally refers to major depressive disorder that has not responded adequately after appropriate treatment trials with antidepressants.

One important benchmark is two or more antidepressant trials at therapeutic doses and adequate durations.

That distinction matters because simply having a list of medications in your chart does not necessarily mean each one received a fair clinical trial.

A medication may have been stopped early because of side effects. The dose may never have reached a therapeutic level. The medication may have been taken inconsistently. Or the treatment may have been discontinued before there was enough time to determine whether it was helping.

A thorough evaluation therefore looks beyond the number of medications you’ve tried.

It considers what you took, the dose, how long you took it, how consistently you took it, what changed, what side effects occurred, and why the medication was ultimately stopped.

Only then can your provider begin to determine whether your depression has truly been resistant to standard treatment or whether there are other factors that need to be addressed first.

Why an “Adequate Trial” Matters

Not every medication that appears in a treatment history represents a medication that genuinely failed.

An antidepressant needs to be evaluated in the right clinical context. That means considering the medication selected, the dose, the duration of treatment, adherence, side effects, and the symptoms being targeted.

For example, if a medication was stopped shortly after starting because of intolerable side effects, it may not be accurate to conclude that the medication was ineffective. Similarly, if the dose remained below a therapeutic range, the medication may never have received a fair opportunity to work.

This is why a detailed medication history is so important when evaluating treatment-resistant depression.

Rather than simply asking, “How many medications have you tried?”, a clinician needs to understand what actually happened during each trial.

That review can sometimes reveal opportunities that were missed previously.

It may show that a medication was effective but poorly tolerated, that a potentially useful treatment was never optimized, or that the treatment approach needs to be reconsidered entirely.

A careful review helps separate genuine treatment resistance from an incomplete treatment trial.

When Depression Looks Treatment-Resistant

Sometimes depression appears resistant because another factor is complicating treatment.

One important possibility is undiagnosed bipolar disorder. Someone experiencing depressive episodes may be treated repeatedly with antidepressants without the underlying mood pattern being recognized. A history of periods of unusually high energy, reduced need for sleep, racing thoughts, or other mood changes can provide important diagnostic information.

Medication dose can also matter. If a medication was never optimized, lack of improvement may not necessarily mean the medication itself was ineffective.

Adherence is another consideration. Depression can make it difficult to maintain a consistent medication routine, particularly when someone is already struggling with motivation, memory, sleep, or daily functioning.

Other psychiatric or medical factors may also contribute to persistent symptoms.

None of these possibilities mean that your symptoms are not real. They mean that persistent depression deserves a closer look before concluding that nothing will work.

A comprehensive evaluation can help identify what may have been missed and whether the current diagnosis and treatment strategy still make sense.

What Comes Next?

When standard antidepressant treatment has not provided enough relief, there may be several paths forward.

Depending on your individual history, treatment may involve augmentation, where another medication is added to support the effect of the existing antidepressant. In other situations, a medication may be changed, adjusted, or combined with another appropriate treatment.

The right approach depends on factors such as your diagnosis, previous medication response, side effects, other psychiatric conditions, medical history, and treatment goals.

For some patients with genuine treatment-resistant depression, Spravato (esketamine) may become an option to consider. Spravato is an FDA-approved nasal spray for treatment-resistant depression and works through a different mechanism than traditional antidepressants.

Eligibility is not automatic. A clinician needs to review your treatment history and determine whether the treatment is clinically appropriate and whether you meet relevant criteria.

The important point is that reaching the treatment-resistant stage does not mean reaching the end of treatment.

It means the treatment strategy may need to become more individualized.

You’re Not Out of Options

If you’ve tried multiple antidepressants and still feel stuck, you deserve more than another medication added without understanding the full history.

A careful review can clarify what has actually been tried, what may have been missed, and which options could make sense next.

Explore [Treatment-Resistant Depression] or learn more about [Spravato — Advanced Treatment Options] to understand your next steps.

AMPLE
GRACE PSYCHIATRY